Biopol Chemicals Limited (NSE:BIOPOL)

Biopol Chemicals Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024
Period Ending	Mar 31, 2025	Mar 31, 2024
Revenue	491.28	174.33
Revenue Growth (YoY)	181.82%	-
Cost of Revenue	402.86	146.42
Gross Profit	88.42	27.91
Selling, General & Admin	14.48	3.5
Other Operating Expenses	8.54	5.62
Operating Expenses	23.73	9.52
Operating Income	64.69	18.38
Interest Expense	-5.05	-0.81
Currency Exchange Gain (Loss)	0.16	-0.02
Other Non Operating Income (Expenses)	-1.77	-0.43
Pretax Income	58.04	17.12
Income Tax Expense	14.74	4.31
Net Income	43.3	12.81
Net Income to Common	43.3	12.81
Net Income Growth	238.08%	-
Shares Outstanding (Basic)	8	-
Shares Outstanding (Diluted)	8	-
EPS (Basic)	5.47	-
EPS (Diluted)	5.47	-
Free Cash Flow	-23.61	-89.43
Free Cash Flow Per Share	-2.98	-
Gross Margin	18.00%	16.01%
Operating Margin	13.17%	10.54%
Profit Margin	8.81%	7.35%
Free Cash Flow Margin	-4.81%	-51.30%
EBITDA	65.39	18.78
EBITDA Margin	13.31%	10.77%
D&A For EBITDA	0.7	0.4
EBIT	64.69	18.38
EBIT Margin	13.17%	10.54%
Effective Tax Rate	25.40%	25.19%
Revenue as Reported	491.51	174.33

Source: S&P Global Market Intelligence. Standard template. Financial Sources.